Role of TNF alpha inhibitors and JAK inhibitors in rheumatological diseases

Speciality: Rheumatology

Description:

A warm welcome to all the medical professionals in this interesting session of ACR updates 2021. 

In this webinar, an elaborative discussion is done ACR 2021 updates. The viewers are going to get extensive knowledge from the ACR paper and posters. The primary subject of discussion in this webinar is immunological responses in rheumatic diseases. TNF alpha inhibitors and JAK inhibitors are the primary focus of discussion.

The speakers Dr. Vineeta Shobha, Dr Sumit Agarwal and Dr Vishnu Sharma have immense knowledge and experience in the field of rheumatology. In this webinar they have discussed how the TNF alpha inhibitors and JAK inhibitors play a key role in altering immune responses in rheumatological diseases.  

TNF alpha inhibitor and JAK inhibitor drugs help in controlling inflammation in different conditions such as rheumatoid arthritis (RA), psoriatic arthritis, juvenile idiopathic arthritis, inflammatory bowel disease (Crohn's and ulcerative colitis), ankylosing spondylitis, and psoriasis. 

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.

See More Webinars @ Hidoc Webinars

See More Webinars @ Hidoc Webinars